GLUTATHIONE MONOETHYL ESTER CAN SELECTIVELY PROTECT LIVER FROM HIGH-DOSE BCNU OR CYCLOPHOSPHAMIDE

被引：0
|
作者：
TEICHER, BA [1 ]
CRAWFORD, JM [1 ]
HOLDEN, SA [1 ]
LIN, Y [1 ]
CATHCART, KNS [1 ]
LUCHETTE, CA [1 ]
FLATOW, J [1 ]
机构：
[1] BRIGHAM & WOMENS HOSP,BOSTON,MA 02115
来源：
CANCER | 1988年 / 62卷 / 07期
关键词：
D O I：
10.1002/1097-0142(19881001)62:7<1275::AID-CNCR2820620705>3.0.CO;2-I
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1275 / 1281
页数：7
相关论文
共 50 条
  • [21] HIGH-DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE AND BCNU WITH NON-CRYOPRESERVED AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR POOR PROGNOSIS HODGKIN'S LYMPHOMA
    Brahimi, M.
    Yafour, N.
    Osmani, S.
    Attaf, F.
    Tadj, H.
    Arabi, A.
    Soltan, B. Enta
    Berredouane, H.
    Benzineb, B.
    Bey, M.
    Bahlat, N.
    Bekadja, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 655 - 656
  • [22] High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy
    M E de Jonge
    A D R Huitema
    J H Beijnen
    S Rodenhuis
    British Journal of Cancer, 2006, 94 : 1226 - 1230
  • [23] High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy
    de Jonge, M
    Huitema, ADR
    Beijnen, JH
    Rodenhuis, S
    BRITISH JOURNAL OF CANCER, 2006, 94 (09) : 1226 - 1230
  • [24] Glutathione, glutathione-dependent enzymes and antioxidant status in erythrocytes from children treated with high-dose paracetamol
    Kozer, E
    Evans, S
    Barr, J
    Greenberg, R
    Soriano, I
    Bulkowstein, M
    Petrov, I
    Chen-Levi, Z
    Barzilay, B
    Berkovitch, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (03) : 234 - 240
  • [25] HIGH-DOSE CYCLOPHOSPHAMIDE, BCNU, AND VP-16 (CBV) AS A CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE-LEUKEMIA
    ZANDER, AR
    CULBERT, S
    JAGANNATH, S
    SPITZER, G
    KEATING, M
    LARRY, N
    COCKERILL, K
    HESTER, J
    HORWITZ, L
    VELLEKOOP, L
    SWAN, F
    MCCREDIE, K
    DICKE, KA
    CANCER, 1987, 59 (06) : 1083 - 1086
  • [26] High-dose cyclophosphamide, BCNU, and VP-16 (CBV) conditioning before allogeneic stem cell transplantation for patients with non-Hodgkin's lymphoma
    H A Rossi
    P S Becker
    R V B Emmons
    P Westervelt
    W Levy
    Q Liu
    Y Clark
    K Ballen
    Bone Marrow Transplantation, 2003, 31 : 441 - 446
  • [27] High-dose cyclophosphamide, BCNU, and VP-16 (CBV) conditioning before allogeneic stem cell transplantation for patients with non-Hodgkin's lymphoma
    Rossi, HA
    Becker, PS
    Emmons, RVB
    Westervelt, P
    Levy, W
    Liu, Q
    Clark, Y
    Ballen, K
    BONE MARROW TRANSPLANTATION, 2003, 31 (06) : 441 - 446
  • [28] TOTAL-BODY IRRADIATION (TBI) AND HIGH-DOSE CYCLOPHOSPHAMIDE IN MINIMAL SYSTEMIC TUMOR DISEASE - EXPERIENCE WITH LIVER AND LUNG METASTASES
    NIEDERWIESER, D
    AULITZKY, W
    FROMMHOLD, H
    MARGREITER, R
    HUBER, C
    BLUT, 1985, 51 (03): : 160 - 161
  • [29] RECONSTITUTION OF HEMATOPOIETIC FUNCTION IN POST-HEPATIC APLASIA FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE AND ALLOGENEIC FETAL LIVER-TRANSPLANTATION
    OREILLY, RJ
    PAHWA, R
    KAGAN, W
    KAPOOR, N
    SORELL, M
    MEYERS, P
    GOOD, RA
    EXPERIMENTAL HEMATOLOGY, 1977, 5 : 46 - 46
  • [30] AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWING HIGH-DOSE CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, BCNU AND VP-16 IN SMALL CELL-CARCINOMA OF THE LUNG AND A REVIEW OF CURRENT LITERATURE
    STAHEL, RA
    TAKVORIAN, RW
    SKARIN, AT
    CANELLOS, GP
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (10): : 1233 - 1238
12345